Acne Clinical Trials

A listing of Acne medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 63 clinical trials
Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar.

The scope of this open label clinical trial is to evaluate and confirm the performance of Papix acne scar in the prevention and improvement of acne scars in subject suffering for mild to

  • 0 views
  • 27 Mar, 2021
  • 1 location
The Effect of Doxycycline 100mg and Doxycycline 20mg in Treatment of Mild and Moderate Acne

The purpose of this study is to compare the safety and efficacy of twice daily subantimicrobial dose doxycycline 20mg with daily doxycycline 100mg in treatment of mild and moderate Acne.

doxycycline
doxycycline 100 mg
  • 44 views
  • 07 Nov, 2020
  • 1 location
Digital Strategies for Patients With Chronic Dermatosis With Pruritus / Skin Picking Disorder

Almost 35% of patients treated to dermatosis have some psychiatric disorder. The aim of this study is to evaluate the prevalence and severity of skin picking disorder and other dermatosis, and also test the efficacy of an online-delivered cognitive-behavioral therapy to improve skin picking disorder severity.

  • 0 views
  • 10 Feb, 2021
  • 1 location
Use of the SpiderMass for in Vivo Analysis of the Skin in Five Chronic Inflammatory Dermatosis

in the research center such as FTIR spectroscopy. Indeed, in acne studies the FTIR allows to obtain only the Fatty Acid Triglycerid ratio while the SpiderMass permits to detail these lipid classes by

retinoid
anti-fungal
tacrolimus
isotretinoin
crust
  • 154 views
  • 26 Mar, 2021
  • 1 location
Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients

The impact of tailored patient-provider communication to improve clinical trial recruitment, patient knowledge, and patient engagement will be studied. Tailored patient-provider communication refers to the individualization of patient-provider communication using patients' preferred methods of communication. This involves the utilization of social messaging such as e-mail or text and/or social media …

  • 0 views
  • 09 Apr, 2021
  • 1 location
Using a Cold Atmospheric Plasma Device to Treat Skin Disorders

This study examines the efficacy of a non-thermal, atmospheric plasma device in the treatment of skin disorders

skin disorders
hair loss
alopecia
cold
skin lesions
  • 0 views
  • 22 Jul, 2021
  • 1 location
Negative Pressure Wound Therapy With Instillation for Treatment of Hidradenitis Suppurativa

The current surgical management for severe Hidradenitis suppurativa (HS) involves wide excision of affected skin, resulting in a large soft tissue defect. The soft tissue defect will then be managed with Negative Pressure Wound Therapy (NPWT) to promote healthy granulation tissue formation for wound coverage with Split skin graft (SSG). …

negative pressure wound therapy
hidradenitis
split skin graft
antibiotics
hospital acquired infection
  • 100 views
  • 25 Jan, 2021
  • 1 location
Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

This study evaluates the effect of hypertonic saline 23.4% injection in fistulas or sinus tracts in adult patients with hidradenitis suppurativa.

sclerotherapy
hidradenitis
  • 257 views
  • 26 Jan, 2021
  • 1 location
Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite Laser

Patients with bilateral hidradenitis in the axilla, groin and/or inframammary will be treated on one side with the Alexandrite hair removal laser. The other side will serve as the control.

hidradenitis
hair removal laser
  • 657 views
  • 25 Jan, 2021
  • 1 location
A Study to Evaluate the Safety and Efficacy of PF-06650833 PF-06700841 and PF 06826647 in Adults With Hidradenitis Suppurativa

This is a study with 3 kinase inhibitors (PF 06650833, PF 06700841 and PF 06826647) in participants with moderate to severe HS. The study will have a maximum duration of approximately 26 weeks. This includes an up to 6-week Screening Period, a 16 week Dosing Period and a 4 week …

hidradenitis
  • 717 views
  • 25 Jul, 2021
  • 88 locations